{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:35:34Z","timestamp":1763037334627,"version":"3.44.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.neurol.2019.07.012","type":"journal-article","created":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T08:33:54Z","timestamp":1564562034000},"page":"417-419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Neurologic manifestations of Lyme Borreliosis"],"prefix":"10.1016","volume":"175","author":[{"given":"G.","family":"Summer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.A.","family":"Rupprecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Pt 2","key":"10.1016\/j.neurol.2019.07.012_bib0175","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/brain\/115.2.399","article-title":"The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production","volume":"115","author":"Hansen","year":"1992","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.neurol.2019.07.012_bib0180","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s100960050381","article-title":"Incidence of Lyme borreliosis in the Wurzburg region of Germany","volume":"18","author":"Huppertz","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.neurol.2019.07.012_bib0185","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1468-1331.2009.02862.x","article-title":"EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis","volume":"17","author":"Mygland","year":"2010","journal-title":"Eur J Neurol"},{"issue":"S1","key":"10.1016\/j.neurol.2019.07.012_bib0190","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijmm.2005.12.003","article-title":"Clinical aspects of neuroborreliosis and post-Lyme disease syndrome in adult patients","volume":"296","author":"Pfister","year":"2006","journal-title":"Int J Med Microbiol"},{"issue":"11","key":"10.1016\/j.neurol.2019.07.012_bib0195","first-page":"583","article-title":"Tick born meningopolyneuritis (Garin-Bujadoux Bannwarth) (author's transl)","volume":"41","author":"Horstrup","year":"1973","journal-title":"Fortschr Neurol Psychiatr Grenzgeb"},{"issue":"3","key":"10.1016\/j.neurol.2019.07.012_bib0200","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF00313682","article-title":"The spirochetal etiology of lymphocytic meningoradiculitis of Bannwarth (Bannwarth's syndrome)","volume":"231","author":"Pfister","year":"1984","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2019.07.012_bib0205","first-page":"765","article-title":"Paralysie par les tiques","volume":"71","author":"Garin","year":"1922","journal-title":"J Med Lyon"},{"issue":"5","key":"10.1016\/j.neurol.2019.07.012_bib0210","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00482-008-0695-z","article-title":"Pain and neuroborreliosis: significance, diagnosis and treatment","volume":"22","author":"Rupprecht","year":"2008","journal-title":"Schmerz"},{"issue":"3","key":"10.1016\/j.neurol.2019.07.012_bib0215","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/cid\/ciw299","article-title":"Course and outcome of early European Lyme neuroborreliosis (Bannwarth syndrome): clinical and laboratory findings","volume":"63","author":"Ogrinc","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"3\u20134","key":"10.1016\/j.neurol.2019.07.012_bib0220","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2119\/2007-00091.Rupprecht","article-title":"The pathogenesis of lyme neuroborreliosis: from infection to inflammation","volume":"14","author":"Rupprecht","year":"2008","journal-title":"Mol Med"},{"issue":"1","key":"10.1016\/j.neurol.2019.07.012_bib0225","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/QCO.0000000000000332","article-title":"Lyme neuroborreliosis","volume":"30","author":"Koedel","year":"2017","journal-title":"Curr Opin Infect Dis"},{"issue":"16","key":"10.1016\/j.neurol.2019.07.012_bib0230","doi-asserted-by":"crossref","first-page":"5410","DOI":"10.1128\/AEM.00116-09","article-title":"A new Borrelia species defined by multilocus sequence analysis of housekeeping genes","volume":"75","author":"Margos","year":"2009","journal-title":"Appl Environ Microbiol"},{"issue":"1\u20132","key":"10.1016\/j.neurol.2019.07.012_bib0235","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jneuroim.2006.02.007","article-title":"Adhesion of Borrelia garinii to neuronal cells is mediated by the interaction of OspA with proteoglycans","volume":"175","author":"Rupprecht","year":"2006","journal-title":"J Neuroimmunol"},{"issue":"3","key":"10.1016\/j.neurol.2019.07.012_bib0240","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/07853899609033125","article-title":"Lyme neuroborreliosis in children","volume":"28","author":"Christen","year":"1996","journal-title":"Ann Med"},{"key":"10.1016\/j.neurol.2019.07.012_bib0245","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0196-0644(05)83017-3","article-title":"The enlarging clinical spectrum of Lyme disease: Lyme cerebral vasculitis, a new disease entity","volume":"19","author":"Brogan","year":"1990","journal-title":"Ann Emerg Med"},{"issue":"5","key":"10.1016\/j.neurol.2019.07.012_bib0250","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1159\/000155982","article-title":"Cerebral vasculitis and stroke in Lyme neuroborreliosis. Two case reports and review of current knowledge","volume":"26","author":"Topakian","year":"2008","journal-title":"Cerebrovasc Dis"},{"issue":"6","key":"10.1016\/j.neurol.2019.07.012_bib0255","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1600-0404.1997.tb00222.x","article-title":"Peripheral neuropathy in acrodermatitis chronica atrophicans \u2013 a late Borrelia manifestation","volume":"95","author":"Kindstrand","year":"1997","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.neurol.2019.07.012_bib0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000213066","article-title":"Borrelia burgdorferi sensu lato diversity and its influence on pathogenicity in humans","volume":"37","author":"Baranton","year":"2009","journal-title":"Curr Probl Dermatol"},{"issue":"2","key":"10.1016\/j.neurol.2019.07.012_bib0265","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.diagmicrobio.2016.11.003","article-title":"A critical appraisal of the mild axonal peripheral neuropathy of late neurologic Lyme disease","volume":"87","author":"Wormser","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"11","key":"10.1016\/j.neurol.2019.07.012_bib0270","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/j.1468-1331.2006.01395.x","article-title":"Chronic polyneuropathy and Lyme disease","volume":"13","author":"Mygland","year":"2006","journal-title":"Eur J Neurol"},{"issue":"14","key":"10.1016\/j.neurol.2019.07.012_bib0275","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJMra072023","article-title":"A critical appraisal of \u201cchronic Lyme disease\u201d","volume":"357","author":"Feder","year":"2007","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.neurol.2019.07.012_bib0280","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/ije\/dyi129","article-title":"Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms","volume":"34","author":"Cairns","year":"2005","journal-title":"Int J Epidemiol"},{"issue":"12","key":"10.1016\/j.neurol.2019.07.012_bib0285","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1093\/cid\/civ735","article-title":"Long-term Assessment of Post-Treatment Symptoms in Patients With Culture-Confirmed Early Lyme Disease","volume":"61","author":"Weitzner","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.neurol.2019.07.012_bib0290","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/02813432.2017.1288812","article-title":"Symptom load and general function among patients with erythema migrans: a prospective study with a 1-year follow-up after antibiotic treatment in Norwegian general practice","volume":"35","author":"Eliassen","year":"2017","journal-title":"Scand J Prim Health Care"},{"issue":"6","key":"10.1016\/j.neurol.2019.07.012_bib0295","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/00365540110080421","article-title":"5-y Follow-up study of patients with neuroborreliosis","volume":"34","author":"Berglund","year":"2002","journal-title":"Scand J Infect Dis"},{"issue":"5","key":"10.1016\/j.neurol.2019.07.012_bib0300","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1600-0404.2010.01482.x","article-title":"European neuroborreliosis: quality of life 30 months after treatment","volume":"124","author":"Eikeland","year":"2011","journal-title":"Acta Neurol Scand"},{"issue":"8","key":"10.1016\/j.neurol.2019.07.012_bib0305","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1080\/00365540600810000","article-title":"Symptoms of post-Lyme syndrome in long-term outcome of patients with neuroborreliosis","volume":"38","author":"Picha","year":"2006","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"10.1016\/j.neurol.2019.07.012_bib0310","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1034\/j.1600-0404.2002.01358.x","article-title":"Chronic symptoms are common in patients with neuroborreliosis -- a questionnaire follow-up study","volume":"106","author":"Vrethem","year":"2002","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"10.1016\/j.neurol.2019.07.012_bib0315","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1086\/518854","article-title":"Point: antibiotic therapy is not the answer for patients with persisting symptoms attributable to lyme disease","volume":"45","author":"Auwaerter","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.neurol.2019.07.012_bib0320","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00415-015-7923-0","article-title":"Prevalence and spectrum of residual symptoms in Lyme neuroborreliosis after pharmacological treatment: a systematic review","volume":"263","author":"Dersch","year":"2016","journal-title":"J Neurol"},{"issue":"5","key":"10.1016\/j.neurol.2019.07.012_bib0325","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/jama.283.5.609","article-title":"Long-term outcomes of persons with Lyme disease","volume":"283","author":"Seltzer","year":"2000","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.neurol.2019.07.012_bib0330","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000008144","article-title":"Chronic fatigue syndrome in patients with Lyme borreliosis","volume":"43","author":"Treib","year":"2000","journal-title":"Eur Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2019.07.012_bib0335","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJM200107123450202","article-title":"Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease","volume":"345","author":"Klempner","year":"2001","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.neurol.2019.07.012_bib0340","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa1505425","article-title":"Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease","volume":"374","author":"Berende","year":"2016","journal-title":"New England J Med"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378719307416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378719307416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:39:30Z","timestamp":1758519570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378719307416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":34,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0035378719307416"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2019.07.012","relation":{},"ISSN":["0035-3787"],"issn-type":[{"type":"print","value":"0035-3787"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurologic manifestations of Lyme Borreliosis","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2019.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}